A subscription to JoVE is required to view this content. Sign in or start your free trial.

Method Article

Using In Vivo and Tissue and Cell Explant Approaches to Study the Morphogenesis and Pathogenesis of the Embryonic and Perinatal Aorta

7.8K views

DOI:

10.3791/56039

September 12th, 2017

In This Article

Summary

Protocols for studying the embryonic and perinatal murine aorta using in vivo clonal analysis and fate mapping, aortic explants, and isolated smooth muscle cells are detailed here. These diverse approaches facilitate the investigation of the morphogenesis of the embryonic and perinatal aorta in normal development and the pathogenesis in disease.

Abstract

The aorta is the largest artery in the body. The aortic wall is composed of an inner layer of endothelial cells, a middle layer of alternating elastic lamellae and smooth muscle cells (SMCs), and an outer layer of fibroblasts and extracellular matrix. In contrast to the widespread study of pathological models (e.g., atherosclerosis) in the adult aorta, much less is known about the embryonic and perinatal aorta. Here, we focus on SMCs and provide protocols for the analysis of the morphogenesis and pathogenesis of embryonic and perinatal aortic SMCs in normal development and disease. Specifically, the four protocols included are: i) in vivo embryonic fate mapping and clonal analysis; ii) explant embryonic aorta culture; iii) SMC isolation from the perinatal aorta; and iv) subcutaneous osmotic mini-pump placement in pregnant (or non-pregnant) mice. Thus, these approaches facilitate the investigation of the origin(s), fate, and clonal architecture of SMCs in the aorta in vivo. They allow for modulating embryonic aorta morphogenesis in utero by continuous exposure to pharmacological agents. In addition, isolated aortic tissue explants or aortic SMCs can be used to gain insights into the role of specific gene targets during fundamental processes such as muscularization, proliferation, and migration. These hypothesis-generating experiments on isolated SMCs and the explanted aorta can then be assessed in the in vivo context through pharmacological and genetic approaches.

Introduction

The circulatory systems of multicellular organisms function to deliver nutrients and oxygen to cells that are not in contact with the external environment and to remove waste products and carbon dioxide from these cells. In vertebrates, the primary circulatory system consists of the heart, which pumps blood through a series of blood vessels. The walls of large blood vessels, such as arteries and veins, consist of three layers: i) the intima, or inner layer of endothelial cells; ii) the media, or middle layer of alternating circumferentially elongated smooth muscle cells SMCs and elastic lamellae; and iii) the adventitia, or outer layer of connective tissue and fibrobl....

Access restricted. Please log in or start a trial to view this content.

Protocol

All mouse protocols are approved by the Institutional Animal Care and Use Committee at Yale University.

1. In Vivo Embryonic Fate Mapping and Clonal Analysis

Note: We have used these approaches widely to evaluate the origins of cells and their clonal architecture in development and disease models7,8,9,10.

  1. Set up mating between mice with a CreER and mice with a Cre reporter.
    NOTE: A CreER is used for SMC marking; Myh11-CreERT2 or Acta2-CreERT2 mice

Access restricted. Please log in or start a trial to view this content.

Results

In a representative clonal analysis of SMCs in embryos mutant for Eln (the gene encoding the extracellular matrix protein elastin), Eln(+/-), Acta2-CreERT2 mice were mated to Eln(+/-) mice also carrying the multi-color ROSA26R(Rb/Rb) reporter. As described in step 1, plugs were checked, pregnant dams were induced with a single tamoxifen injection (1.5 mg) at E12.5, and they were sacrificed at E18.5. Embryos were harves.......

Access restricted. Please log in or start a trial to view this content.

Discussion

In contrast to the extensive investigations of the murine aorta and its major branches in adult pathological conditions, such as models of atherosclerosis, less is known regarding the morphogenesis and the pathogenesis of the embryonic and perinatal aorta. Here, we focus on the embryonic/perinatal aorta, specifically the SMCs, and provide protocols to study the aorta through in vivo, tissue explant, and SMC isolation approaches. These complimentary approaches provide the investigator with diverse approaches to s.......

Access restricted. Please log in or start a trial to view this content.

Disclosures

The authors have nothing to disclose.

Acknowledgements

We thank Dean Li for sharing his laboratory's protocol for aortic SMC isolation. Funding support was provided by the National Institutes of Health (R21NS088854, R01HL125815, and R01HL133016 to D.M.G), the American Heart Association (Grant-in-Aid 14GRNT19990019 to D.M.G.), and Yale University (Brown-Coxe Fellowship to A.M. and startup funds to D.M.G.).

....

Access restricted. Please log in or start a trial to view this content.

Materials

List of materials used in this article
NameCompanyCatalog NumberComments
TamoxifenSigmaT5648
Corn oilSigmaC-8267Vehicle for tamoxifen
4-OH-tamoxifenSigmaH7904Active metabolite of tamoxifen
ProgesteroneSigmaP8783-5GUse at half the concentration of tamoxifen
OCT compoundSakura tissue tek4583For making cryoblocks
CryomoldsPolysciences inc18986
DAPISigmaD9542IHC staining of nucleus, final concentration 5 mg/mL
Cy3 directly conjugated anti-SMA antibodySigmaA2547IHC staining of SMA, final dilution 1:500
Anti-CD31 antibodyBD Pharmingen550274IHC staining of GFP, final concentration 0.006 mg/mL
Anti-GFP antibodyThermo Fisher ScientificA-11121IHC staining of CD31, final concentration 0.0016 mg/mL
Secondary antibody goat anti-rabbit, Alexa 647Life Technologiesa21244IHC staining, final concentration 0.004 mg/mL
Secondary antibody goat anti-rabbit, Alexa 488Life Technologiesa11008IHC staining, final concentration 0.004 mg/mL
DMEMThermo Fisher Scientific10567-014For cell culture
FBSThermo Fisher Scientific10437028
Anti-integrin beta3 blocking antibodyBD Biosciences553343Clone 2C9.G2, final concentration 0.02 mg/mL
CollagenaseWorthington Biochemical Corp44H14977AFor digesting aorta
ElastaseWorthington Biochemical Corp34K15139For digesting aorta
Antibiotic-antimycotic (100X)Thermo Fisher Scientific15240062
Recombinant human FGFPromegaG5071
Recombinant human EGFPromegaG5021
Penicillin/streptomycin (10,000 U/mL)Thermo Fisher Scientific15140122
Amphotericin BThermo Fisher Scientific15290026
Tissue culture platesCorningCLS430165
Alzet osmotic mini-pumpDurect Corporation2001
ECLIPSE 80i Upright Fluorescent MicroscopeNikon 
 TCS SP5Leica
Branson Sonifier 450VWR
Myh11-CreERT2 miceThe Jackson Laboratory 19079
Acta2-CreERT2 miceObtained from lab of Dr. Pierre Chambon and Daniel Metzger
ROSA26R-CreERT2 miceThe Jackson Laboratory 8463
ROSA26R(mTmG/mTmG) miceThe Jackson Laboratory  026862
ROSA26R(EYFP/EYFP) miceThe Jackson Laboratory  006148 
ROSA26R(Confetti/Confetti) miceThe Jackson Laboratory 13731
ROSA26R(Rb/Rb) miceLab of Dr. Irv WeissmanObtained from lab of Dr. Irv Weissman

References

  1. Shankman, L. S., et al. KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis. Nat Med. 21, 628-637 (2015).
  2. Rowe, V. L., et al. Vascular smoo....

Access restricted. Please log in or start a trial to view this content.

Reprints and Permissions

Tags

Embryonic AortaSmooth Muscle CellsIn Vivo Fate MappingExplant Aorta CultureSmooth Muscle Cell IsolationOsmotic Mini PumpClonal AnalysisTissue SectioningFluorescent Microscopy